X-linked ADGRG2 gene mutation has been verified to be associated with CAVD in recent years and is responsible for approximately 20% of CAVD not related to CFTR mutation (Patat et al., 2016; Bieth et al., 2021). The gene discussed is CFTR; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.